LifeArc Ventures
London, Englandlifearcventures.com
Overview
LifeArc Ventures invests in early-stage science-led companies that can benefit from their advice, scientific insight and venture funding . They have built a portfolio of exceptional companies with outstanding innovation and inspiring leadership . They invest across the full spectrum of therapeutics, HealthTech and medical devices . As part of the medical research charity LifeArc, they offer a unique combination of scientific, commercial and financial support .
Portfolio Companies
10
Website
lifearcventures.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cytospire Therapeutics | May 2026 | Series A | Co-investor |
| Exciva GmbH | Jan 2026 | Series B | Co-investor |
| Affect Therapeutics | Nov 2025 | Series B | Co-investor |
| GlycoEra | May 2025 | Series B | Co-investor |
| Tribune Therapeutics | Mar 2025 | Series A | Lead |
Key People
Sohaib Mir
Partner
Diana Röttger
Investment Principal
Jon Nash
Investment Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.